MRVL vs NVDA

Marvell Technology trades at a premium valuation with strong year-over-year revenue and earnings growth, supported by solid operating margins and a healthy balance sheet. However, near-term price momentum is negative, with the stock down 4.4% over the past year and 4.9% in the last week, despite a 35.8% six-month rebound from lows. The company's profitability metrics are mixed, with a negative net margin and ROE, while insider selling adds caution. Relative to peers like SNPS and SNOW, MRVL exhibits better financial health and growth than many, but its forward valuation appears stretched against earnings quality and analyst target alignment.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.